IRIS UniCatt

Rossi, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.244
AS - Asia 3.279
EU - Europa 2.965
SA - Sud America 557
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 100
OC - Oceania 12
Totale 13.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.019
SG - Singapore 1.680
DE - Germania 722
CN - Cina 674
IT - Italia 627
SE - Svezia 453
BR - Brasile 441
FR - Francia 248
VN - Vietnam 231
GB - Regno Unito 153
UA - Ucraina 146
IE - Irlanda 132
PL - Polonia 124
BD - Bangladesh 107
IN - India 106
CA - Canada 100
ID - Indonesia 90
RU - Federazione Russa 85
HK - Hong Kong 77
FI - Finlandia 75
JP - Giappone 58
AR - Argentina 43
IQ - Iraq 42
MX - Messico 41
LT - Lituania 35
AT - Austria 34
NL - Olanda 28
SA - Arabia Saudita 27
TR - Turchia 25
ZA - Sudafrica 24
KR - Corea 22
VE - Venezuela 20
ES - Italia 19
BE - Belgio 17
CI - Costa d'Avorio 16
PK - Pakistan 16
PH - Filippine 13
EC - Ecuador 12
IL - Israele 12
JM - Giamaica 12
MY - Malesia 12
CO - Colombia 11
IR - Iran 11
AU - Australia 10
CL - Cile 10
GT - Guatemala 10
KE - Kenya 10
PE - Perù 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
MA - Marocco 9
TH - Thailandia 9
CH - Svizzera 8
HN - Honduras 8
HU - Ungheria 8
SC - Seychelles 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
DZ - Algeria 7
PR - Porto Rico 7
TN - Tunisia 7
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
GP - Guadalupe 6
NI - Nicaragua 6
UY - Uruguay 6
EE - Estonia 5
KZ - Kazakistan 5
LV - Lettonia 5
NP - Nepal 5
OM - Oman 5
RO - Romania 5
AL - Albania 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JO - Giordania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
KH - Cambogia 3
MK - Macedonia 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AD - Andorra 2
AM - Armenia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
TW - Taiwan 2
TZ - Tanzania 2
Totale 13.139
Salva come PNG Salva come JPEG
Città #
Singapore 1.058
Ashburn 607
San Jose 488
Chandler 485
Dallas 197
Rome 147
Beijing 135
New York 125
Dublin 123
Los Angeles 117
Jacksonville 105
Council Bluffs 97
Wilmington 95
Warsaw 91
Milan 89
San Mateo 86
Fairfield 80
Ho Chi Minh City 80
Jakarta 80
Munich 76
Lauterbourg 70
Hong Kong 69
Ann Arbor 66
Houston 66
Boston 64
Hanoi 63
Hefei 62
Cattolica 61
Dearborn 61
Nanjing 61
Chicago 56
Woodbridge 56
Atlanta 48
Seattle 48
Tokyo 48
Frankfurt am Main 47
Santa Clara 46
São Paulo 45
Marseille 39
Moscow 39
Princeton 38
The Dalles 37
Hyderabad 33
North Bergen 33
Orem 32
Redwood City 32
Boardman 29
Buffalo 29
Detroit 29
Phoenix 28
Toronto 28
Helsinki 27
Brooklyn 26
Lawrence 26
Vilnius 26
Nürnberg 25
Bologna 23
Kraków 23
Redmond 23
London 22
Montreal 22
Nanchang 22
Nuremberg 22
Cambridge 20
Hangzhou 20
San Francisco 19
Mexico City 18
Paris 18
St Louis 18
Washington 18
Hebei 17
Seoul 17
Abidjan 16
Brussels 16
Belo Horizonte 15
Denver 15
Kent 15
Las Vegas 15
Vienna 15
Guangzhou 14
Leawood 14
Norwalk 14
Stockholm 14
San Diego 13
Da Nang 12
Johannesburg 12
Memphis 12
Tianjin 12
Baghdad 11
Chennai 11
Florence 11
Lappeenranta 11
Shanghai 11
Amsterdam 10
Changsha 10
Dhaka 10
Düsseldorf 10
Ealing 10
Guatemala City 10
Rio de Janeiro 10
Totale 6.625
Salva come PNG Salva come JPEG
Nome #
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 464
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 392
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 360
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 341
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 332
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 314
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 292
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 255
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 255
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 254
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 251
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 247
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 215
Risk factor and etiology analysis of ischemic stroke in young adult patients 215
High Frequency of Germline ATM Variants in Familial Philadelphia-Negative Myeloproliferative Neoplasms 210
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 198
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 190
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 189
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 186
Venous thromboembolism in multiple myeloma 181
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 179
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 178
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 178
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 173
Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study 169
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 167
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 167
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 166
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 165
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 163
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 158
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 155
Assessment of congenital neutropenia in children: common clinical sceneries and clues for management 155
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 154
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 153
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 149
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 146
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 146
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 143
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 141
Inherited thrombophilia: treatment during pregnancy. 140
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 140
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 137
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 135
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 132
Reassessment of contractile reserve after revascularization of akinetic myocardium 131
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 130
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 129
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 129
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 127
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 122
Coagulopathy in CAR-T: Critical concern or mere blip? 120
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 118
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 117
Cerebral sinus-venous thrombosis 117
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 116
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases 115
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 113
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 111
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 111
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 111
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 109
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 108
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 107
Structural analysis of protein Z gene variants in patients with foetal losses 107
Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia 104
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 101
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: An expert consensus 101
Venous thromboembolism in patients with liver diseases 100
Glycoprotein la C807T qene polymorphism and increased risk of recurrent acute coronary syndromes: A five year follow up 100
Risk factor and etiology analysis of ischemic stroke in young adult patients 99
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 99
Venous thromboembolism in patients with liver diseases 98
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? 96
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases 91
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 91
Second cancers in MPN: Survival analysis from an international study 88
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms 83
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera 78
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 77
Left atrial myxoma supplied from the right coronary artery 67
Glycoprotein IA C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. 62
ROLE OF 18 F-FDG PET/CT IN THE ASSESSMENT OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA 61
The impact of daratumumab-containing induction on stem cell mobilization, collection and engraftment in newly diagnosed multiple myeloma: results of the prospective DILEMMA study 48
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-Analysis 32
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea 30
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study 25
The risk of thrombosis in patients with acute leukemia: Occurrence of thrombosis at diagnosis and during treatment 15
Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome 9
Totale 13.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022531 0 0 0 0 32 13 20 80 45 45 121 175
2022/20231.356 203 197 115 199 77 159 79 84 154 25 35 29
2023/2024742 28 177 30 52 34 127 37 40 14 31 80 92
2024/20251.552 26 67 91 62 121 37 59 71 254 165 325 274
2025/20264.490 601 120 319 416 916 191 705 216 281 293 212 220
2026/20272.559 213 1.154 292 748 152 0 0 0 0 0 0 0
Totale 13.333